lunes, 2 de marzo de 2020

Antigen-based metric could better predict which patients benefit from immunotherapy, study says By SHAFAQ ZIA

https://www.statnews.com/2020/02/21/antigen-based-metric-could-better-predict-which-patients-benefit-from-immunotherapy-study-says/?utm_source=STAT+Newsletters&utm_campaign=82ff5a5dd9-Cancer_Briefing&utm_medium=email&utm_term=0_8cab1d7961-82ff5a5dd9-149692869
Cancer Briefing

Antigen-based metric could better predict which patients benefit from immunotherapy, study says

By SHAFAQ ZIA

MATTHEW DANIELS/WELLCOME
The new metric looks at the specific genetic profiles of each neoantigen to sort out which ones might bode well for treatment.

No hay comentarios: